Oncology & Cancer

Increased risk of prostate cancer in men with BRCA2 gene fault

Men with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect the disease earlier, according to researchers funded by Cancer Research ...

Oncology & Cancer

When should NHS contact patients over faulty genes?

The NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the current lack of guidance creates a dilemma for health services, experts have warned.

page 12 from 35